UMB Bank, n.a. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
UMB Bank, n.a. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$9,341
-20.5%
1860.0%0.00%
Q2 2023$11,755
-13.2%
186
-38.2%
0.00%
Q1 2023$13,542
+225600.0%
301
+110.5%
0.00%
Q4 2022$6
-99.9%
1430.0%0.00%
Q3 2022$9,000
+12.5%
143
-5.3%
0.00%
Q2 2022$8,000
-20.0%
1510.0%0.00%
Q1 2022$10,000
-47.4%
151
-15.6%
0.00%
Q4 2021$19,0001790.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders